Back
Cara Therapeutics Stock Price Chart
Sponsored
CARA
Sponsored
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free
Sell
27
CARA
Cara Therapeutics
Last Price:
$4.82
Seasonality Move:
10.97%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the power of "two-minute trades"
Learn how today!-
The current trend is moderately bullish and CARA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.16 | Sell |
20-day SMA: | 4.55 | Buy |
50-day SMA: | 3.99 | Buy |
200-day SMA: | 5.22 | Sell |
8-day EMA: | 4.98 | Sell |
20-day EMA: | 4.67 | Buy |
50-day EMA: | 4.19 | Buy |
200-day EMA: | 7.22 | Sell |
Cara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.38 | Buy |
Relative Strength Index (14 RSI): | 53.38 | Buy |
Chaikin Money Flow: | 79077 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.25 - 5.35) | Buy |
Bollinger Bands (100): | (3.07 - 4.45) | Buy |
Cara Therapeutics Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cara Therapeutics Stock
Is Cara Therapeutics Stock a Buy?
-
Cara Therapeutics share price is 4.75 while CARA 8-day simple moving average is 5.16, which is a Sell signal.
-
The stock price of CARA is 4.75 while Cara Therapeutics 20-day SMA is 4.55, which makes it a Buy.
-
Cara Therapeutics 50-day simple moving average is 3.99 while CARA share price is 4.75, making it a Buy technically.
-
CARA stock price is 4.75 and Cara Therapeutics 200-day simple moving average is 5.22, creating a Sell signal.
CARA Technical Analysis vs Fundamental Analysis
Sell
27
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy or a Sell?
-
Cara Therapeutics stock is rated a SellThe current Cara Therapeutics [CARA] share price is $4.75. The Score for CARA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Cara Therapeutics Stock Info
Market Cap:
21.7M
Price in USD:
4.75
Share Volume:
134.6K
Cara Therapeutics 52-Week Range
52-Week High:
13.80
52-Week Low:
2.71
Sell
27
Cara Therapeutics (CARA)
is a Sell
Cara Therapeutics Share Price Forecast
-
What is the Cara Therapeutics stock price today?The Cara Therapeutics stock price is 4.75 USD today.
-
Will CARA stock go up or go down?Cara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cara Therapeutics is overvalued.
Is Cara Therapeutics Stock a Buy?
-
Cara Therapeutics share price is 4.75 while CARA 8-day exponential moving average is 4.98, which is a Sell signal.
-
The stock price of CARA is 4.75 while Cara Therapeutics 20-day EMA is 4.67, which makes it a Buy.
-
Cara Therapeutics 50-day exponential moving average is 4.19 while CARA share price is 4.75, making it a Buy technically.
-
CARA stock price is 4.75 and Cara Therapeutics 200-day simple moving average is 7.22, creating a Sell signal.
Fundamental Analysis of Cara Therapeutics
Is Cara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Cara Therapeutics
Should I short Cara Therapeutics stock?
-
CARA Moving Average Covergence Divergence (MACD) indicator is 0.38, suggesting Cara Therapeutics is a Buy
-
Cara Therapeutics Relative Strength Index (RSI) is 53.38, which suggest Cara Therapeutics is overbought
-
The Bollinger Bands (25) for Cara Therapeutics is (3.25 - 5.35), which suggest Cara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cara Therapeutics is (3.07 - 4.45), which suggest Cara Therapeutics is a Buy
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.